Reports on the recommendation of U.S. working group that reviewed National Institutes of Health's (NIH) system to bring the NIH Recombinant DNA Advisory committee without formally voting on acceptability of proposals. Non-agreement of members on the proposal for changing the reporting of clinical trials; Transmission of information on adverse events to Food & Drug Administration.